UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 24, 2022 4:00 P.M.
Form: S-3
CIK: 0001445499
Company Name: IMPEL PHARMACEUTICALS INC
File Number: 333-264987